Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 293-209-3 | CAS number: 91052-49-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- weight of evidence
- Study period:
- 18 Apr - 24 Apr 2007
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- GLP - Guideline study. According to the ECHA guidance document "Practical guide 6: How to report read-across and categories (March 2010)", the reliability was changed from RL1 to RL2 to reflect the fact that this study was conducted on a read-across substance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hess. Ministerium für Umwelt, ländlichen Raum und Verbraucherschutz, Wiesbaden, Germany
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 736150-63-3
- EC Number:
- 616-005-1
- Cas Number:
- 736150-63-3
- Molecular formula:
- C25H46 O6; C27H48O8
- IUPAC Name:
- 736150-63-3
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA7CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Netherlands, Horst, The Netherlands
- Age at study initiation: 7-8 weeks
- Weight at study initiation: 19.4 ± 0.9 g
- Housing: animals were housed individually in Makrolon Type I cages with wire mesh top (EHRET GmbH, Emmedingen, Germany) and granulated soft wood bedding (Harlan Winkelmann GmbH, Borchen, Germany)
- Diet: pelleted standard diet (Harlan Winkelmann GmbH, Borchen, Germany), ad libitum
- Water: tap water, ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- dimethyl sulphoxide
- Concentration:
- 10, 20 and 50% (w/v)
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS:
- Study design: 50% (Batch D) was tested in a non-GLP pre-experiment
- Compound solubility: insoluble in water, soluble in DMSO
- Lymph node proliferation response: DPM-Background (1 mL 5% trichloroacetic acid) per animal (2 lymph nodes) controls: 2707.1 (animal 1), 2357.9 (animal 2), 2199.6 (animal 3), 2336.3 (animal 4) and 3184.5 (animal 5); DPM-Background (1 mL 5% trichloroacetic acid) per animal (2 lymph nodes) test group: 6794.2 (animal 1), 5977.4 (animal 2), 6981.8 (animal 3), 7739.5 (animal 4), 6305.7 (animal 5)
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: ³H-methyl thymidine incorporation determined by β-scintillation and γ-counting, respectively
- Criteria used to consider a positive response: A test item was regarded as a sensitiser in the LLNA if the following criteria were fulfilled: The exposure to at least one concentration of the test item resulted in an incorporation of ³HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the stimulation index. The data were compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression. The decision to select a stimulation index (SI) of 3 as an arbitrary indication of sensitising activity was made on the basis of investigations performed with a wide range of chemicals.
TREATMENT PREPARATION AND ADMINISTRATION: Each test group was treated by topical (epidermal) application to the dorsal surface of each ear lobe (left and right) with different test item concentrations. The application volume, 25 µL, was spread over the entire dorsal surface of each ear lobe once daily for 3 consecutive days. A further group of mice was treated with an equivalent volume of the relevant vehicle alone (control animals). Five days after the first topical application, all mice were administered with 250 µL of 80.6 µCi/mL ³HTdR (corresponds to 20.2 µCi ³HTdR per mouse) by intravenous injection via a tail vein. Five hours later, all mice were euthanized by intraperitoneal injection of Na-thiopental. The draining lymph nodes were rapidly excised and pooled per animal (2 nodes per animal). Single cell suspensions in PBS of pooled lymph node cells were prepared by gentle mechanical disaggregation through stainless steel gauze (200 µm mesh size). After washing two times with PBS the lymph node cells were resuspended in 5% trichloroacetic acid and incubated at approximately 4 °C for at least 18 h for precipitation of macromolecules. The precipitates were resuspended in 5% trichloroacetic acid and transferred to plastic scintillation vials. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated in the body weight tables. An ANOVA (Kruskal Wallis) followed by a Dunnett-test or t-test (Mann-Whitney), when applicable, were conducted to assess whether the difference of DPM per animal was statistically significant between test item groups or the positive control (RCA) group and the negative control (vehicle) group. However, both biological and statistical significance were considered together.
Results and discussion
- Positive control results:
- The positve control substance (25% hexyl cinnamic aldehyde in acetone:olive oil (4+1)) induced positive reactions in 2/5 animals (40%).The SI-values of the positive control were 2.3, 1.6, 2.6, 4.2 and 4.8, respectively.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- In the study, stimulation indices of at the maximum 0.97 in the 10% groups, 1.53 in the 25% groups and 1.86 in the 50% groups were observed. At a concentration of 50% of Batch A a statistically significant difference of DPM per animal was observed (p ≤ 0.05), however, the stimulation index (S.I.) was 1.71. EC3 values of the test groups could not be calculated, since none of the tested concentrations induced a S.I. greater than 3.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- The animals treated with Batch B, C and D did not show any clinical signs during the course of the study and no cases of mortality were observed. The animals treated with the mid- and the highest-dose (25% and 50%) of Batch A showed reddening of the ear skin from the second day of treatment. At the concentration of 50% of Batch A a statistically significant difference of DPM per animal was observed (p ≤ 0.05). All other test groups did not show a statistically significant different response from the vehicle control. The effects observed for Batch A seemed to be dose-dependent. The effects observed for Batch B and D seemed to be dose-dependent but this was not confirmed by statistical analysis. The effects seen for Batch 3 were not dose-dependent.
Any other information on results incl. tables
VEHICLE CONTROL DATA:
DPM values per lymph node obtained for the vehicle control were relatively high when compared to the historical control data. The results for the individual animals showed low variability and the results are nonetheless considered as reliable. Differences in vehicle control data when compared to other studies are related to the use of different batches of 3H-Thymidine. Experiments performed with the same batch of 3H-Thymidine as used in the present study have shown DPM values per lymph node, which were considerably higher than the results obtained with earlier and later batches. It is assumed that incorporation of 3H-Thymidine is more efficient with the present batch even though evidence for this hypothesis cannot be provided. Since all animals used for this study were labeled with the same 3H-Thymidine-solution this increase is supposed to be higher for all test groups and does neither affect the sensitivity of the assay nor the calculation of S.l. values.
Table 1. Results of the LLNA.
Test item |
Group |
Calculation |
DPM per |
Result |
number of |
S.I. |
|||
- |
BG_I |
|
37.1* |
|
- |
BG_II |
|
17.89* |
|
- |
Control group |
10 |
2027.9 |
1.0 |
25 |
Positive control Group |
10 |
6312.4** |
3.11 |
10 |
Test group Batch A |
10 |
1528.3 |
0.75 |
25 |
Test group Batch A |
10 |
2088.3 |
1.03 |
50 |
Test group Batch A |
10 |
3468.7** |
1.71 |
10 |
Test group Batch B |
10 |
1964.4 |
0.97 |
25 |
Test group Batch B |
10 |
3107.2 |
1.53 |
50 |
Test group Batch B |
10 |
3768.4 |
1.86 |
10 |
Test group Batch C |
10 |
1211.2 |
0.60 |
25 |
Test group Batch C |
10 |
2295.3 |
1.13 |
50 |
Test group Batch C |
10 |
2213.7 |
1.09 |
10 |
Test group Batch D |
10 |
1225.7 |
0.60 |
25 |
Test group Batch D |
10 |
1688.8 |
0.83 |
50 |
Test group Batch D |
10 |
2868.6 |
1.41 |
* Measurement of DPM only.
** Mean DPM value for the group was according to the Dunnett test significanlty higher than the corresponding control value. The p value for the analysis was <0.05
BG = Background (1 mL 5% trichloroacetic acid) in duplicate
S.I. = Stimulation Index
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- CLP: not classified
DSD: not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.